620 related articles for article (PubMed ID: 33276740)
21. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.
Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN
Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593
[TBL] [Abstract][Full Text] [Related]
22. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
[TBL] [Abstract][Full Text] [Related]
23. Detection of human papillomavirus in male and female urine by electrochemical DNA chip and PCR sequencing.
Nilyanimit P; Wanlapakorn N; Niruthisard S; Pohthipornthawat N; Karalak A; Laowahutanont P; Phanuphak N; Gemma N; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(9):5519-25. PubMed ID: 24175852
[TBL] [Abstract][Full Text] [Related]
24. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
25. Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
Ebisch RMF; Ketelaars PJW; van der Sanden WMH; Schmeink CE; Lenselink CH; Siebers AG; Massuger LFAG; Melchers WJG; Bekkers RLM
PLoS One; 2018; 13(10):e0206219. PubMed ID: 30356297
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
[TBL] [Abstract][Full Text] [Related]
27. A Head-to-Head Analytical Comparison of Cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs.
Jaworek H; Koudelakova V; Drabek J; Vrbkova J; Zborilova B; Oborna I; Brezinova J; Marek R; Huml K; Vanek P; Hajduch M
J Mol Diagn; 2018 Nov; 20(6):849-858. PubMed ID: 30165205
[TBL] [Abstract][Full Text] [Related]
28. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
[TBL] [Abstract][Full Text] [Related]
29. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
Van Keer S; Peeters E; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Vorsters A; Arbyn M
Gynecol Oncol; 2021 Sep; 162(3):575-583. PubMed ID: 34172287
[TBL] [Abstract][Full Text] [Related]
30. Human Papillomavirus Genotype Detection and Cytology Using a New Self-Sampling Method.
Yabusaki H; Ono M; Shiina N; Shiina Y
Asian Pac J Cancer Prev; 2024 May; 25(5):1673-1679. PubMed ID: 38809639
[TBL] [Abstract][Full Text] [Related]
31. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
[TBL] [Abstract][Full Text] [Related]
32. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
[TBL] [Abstract][Full Text] [Related]
33. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
[TBL] [Abstract][Full Text] [Related]
34. A comparison of high-risk human papillomavirus DNA detection between urine and cervical sample testing in women with abnormal Pap smears.
Punyashthira A; Horthongkham N; Jaishuen A; Jareemit N; Achariyapota V
J Obstet Gynaecol Res; 2022 Feb; 48(2):448-455. PubMed ID: 34750932
[TBL] [Abstract][Full Text] [Related]
35. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
[TBL] [Abstract][Full Text] [Related]
36. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
37. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
38. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
39. Performance of urine samples compared to cervical samples for detection of precancer lesions among HPV-positive women attending colposcopy clinic in Mexico City.
Meneses-León J; Hernández-Salazar S; Torres-Ibarra L; Hernández-López R; Rivera-Paredez B; Robles-Rivera K; Lazcano-Ponce E; García-Vera A; Godínez-Pérez M; León-Maldonado L; Salmerón J
Cancer Causes Control; 2024 Jun; 35(6):935-942. PubMed ID: 38368574
[TBL] [Abstract][Full Text] [Related]
40. Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN.
Dijkstra MG; Heideman DA; van Kemenade FJ; Hogewoning KJ; Hesselink AT; Verkuijten MC; van Baal WM; Boer GM; Snijders PJ; Meijer CJ
J Clin Virol; 2012 Jun; 54(2):147-51. PubMed ID: 22445557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
